Mojca Jensterle, Nika Aleksandra Kravos, Marija Pfeifer, Tomaz Kocjan, Andrej Janez
OBJECTIVE: The long-acting glucagon-like peptide 1 receptor agonist liraglutide is linked to progressive and sustained weight loss in obese people with diabetes. However, its efficacy and safety in women with polycystic ovary syndrome (PCOS) has not yet been addressed …